Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Clin Ther. 2022 Mar;44(3):e45-e57. doi: 10.1016/j.clinthera.2022.01.008. Epub 2022 Feb 4.
Ammonia is central to the pathophysiology of hepatic encephalopathy (HE) in cirrhosis. Serum ammonia levels have prognostic value and have been implicated in sarcopenia, hepatotoxicity, and immune dysfunction. Studies indicate that clinicians frequently order serum ammonia levels in decompensated cirrhosis; however, the clinical utility of serum ammonia levels has been questioned, citing challenges in accurate measurement and interpretation. This article involves a primary review of the literature to evaluate the importance of serum ammonia in cirrhosis and examines the clinical utility of serum ammonia levels in the management of HE. In addition to the review, we conducted primary research using national claims data to investigate national trends in practitioner use of serum ammonia.
We identified all hospitalizations in a national commercial claims database with and without ammonia testing among adults with noncirrhotic chronic liver disease and cirrhosis from January 1, 2007, to September 31, 2015. We calculated the proportion of hospitalizations with ammonia testing and the number of ammonia tests per 1000 hospital-days.
Proportion of hospitalizations with ammonia testing and ammonia tests per 1000 inpatient-days increased significantly from 2007 to 2015, and particularly in 2014 and 2015, for all groups.
A review of the literature indicated that elevated serum ammonia contributes to neurotoxicity, sarcopenia, and immune dysfunction in cirrhosis. However, serum ammonia testing has not had consistent benefit in clinical diagnosis or management of HE in cirrhosis. Claims data indicated that ammonia testing increased substantially during the study period, particularly after the advent of electronic medical record systems. The rapid increase in testing may suggest that electronic health records play a crucial role in test volume by facilitating easy ordering and could be leveraged to improved value-based serum ammonia ordering. Serum ammonia levels may also benefit from standardized guidelines on collection, laboratory analysis, and interpretation.
氨在肝硬化肝性脑病(HE)的病理生理学中起着核心作用。血清氨水平具有预后价值,并与肌肉减少症、肝毒性和免疫功能障碍有关。研究表明,临床医生经常在失代偿性肝硬化中检测血清氨水平;然而,由于准确测量和解释方面的挑战,血清氨水平的临床实用性受到了质疑。本文主要对文献进行了回顾,以评估血清氨在肝硬化中的重要性,并研究了血清氨水平在 HE 管理中的临床应用。除了综述,我们还利用国家索赔数据进行了初步研究,以调查全国医生使用血清氨的趋势。
我们从 2007 年 1 月 1 日至 2015 年 9 月 31 日,在全国商业索赔数据库中确定了所有非肝硬化慢性肝病和肝硬化成人住院患者的检测和未检测氨的住院病例。我们计算了检测氨的住院患者比例以及每 1000 个住院日的氨检测次数。
从 2007 年到 2015 年,所有组别的检测氨的住院患者比例和每 1000 个住院日的氨检测次数都显著增加,尤其是在 2014 年和 2015 年。
文献综述表明,血清氨升高会导致肝硬化中的神经毒性、肌肉减少症和免疫功能障碍。然而,血清氨检测在肝硬化 HE 的临床诊断或管理中并没有一致的获益。索赔数据表明,在研究期间,检测数量大幅增加,尤其是在电子病历系统出现之后。检测数量的快速增加可能表明电子病历系统通过方便的医嘱输入在检测量方面发挥了关键作用,并可以利用这一点来改进基于价值的血清氨医嘱输入。血清氨水平也可能受益于关于采集、实验室分析和解释的标准化指南。